307 related articles for article (PubMed ID: 33675038)
1. Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.
Sittig SP; van Beek JJP; Flórez-Grau G; Weiden J; Buschow SI; van der Net MC; van Slooten R; Verbeek MM; Geurtz PBH; Textor J; Figdor CG; de Vries IJM; Schreibelt G
Eur J Immunol; 2021 Jun; 51(6):1494-1504. PubMed ID: 33675038
[TBL] [Abstract][Full Text] [Related]
2. The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells.
Jochems C; Fantini M; Fernando RI; Kwilas AR; Donahue RN; Lepone LM; Grenga I; Kim YS; Brechbiel MW; Gulley JL; Madan RA; Heery CR; Hodge JW; Newton R; Schlom J; Tsang KY
Oncotarget; 2016 Jun; 7(25):37762-37772. PubMed ID: 27192116
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.
Hwu P; Du MX; Lapointe R; Do M; Taylor MW; Young HA
J Immunol; 2000 Apr; 164(7):3596-9. PubMed ID: 10725715
[TBL] [Abstract][Full Text] [Related]
4. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
[TBL] [Abstract][Full Text] [Related]
5. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity.
Liu X; Shin N; Koblish HK; Yang G; Wang Q; Wang K; Leffet L; Hansbury MJ; Thomas B; Rupar M; Waeltz P; Bowman KJ; Polam P; Sparks RB; Yue EW; Li Y; Wynn R; Fridman JS; Burn TC; Combs AP; Newton RC; Scherle PA
Blood; 2010 Apr; 115(17):3520-30. PubMed ID: 20197554
[TBL] [Abstract][Full Text] [Related]
7. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
[TBL] [Abstract][Full Text] [Related]
8. Ambivalent effects of dendritic cells displaying prostaglandin E2-induced indoleamine 2,3-dioxygenase.
Lanzinger M; Jürgens B; Hainz U; Dillinger B; Raberger J; Fuchs D; Heitger A
Eur J Immunol; 2012 May; 42(5):1117-28. PubMed ID: 22539287
[TBL] [Abstract][Full Text] [Related]
9. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.
Boasso A; Herbeuval JP; Hardy AW; Anderson SA; Dolan MJ; Fuchs D; Shearer GM
Blood; 2007 Apr; 109(8):3351-9. PubMed ID: 17158233
[TBL] [Abstract][Full Text] [Related]
10. Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.
Colvin BL; Sumpter TL; Tokita D; Salati J; Mellor AL; Thomson AW
Hum Immunol; 2009 May; 70(5):313-20. PubMed ID: 19208362
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.
Funeshima N; Fujino M; Kitazawa Y; Hara Y; Hara Y; Hayakawa K; Okuyama T; Kimura H; Li XK
J Gene Med; 2005 May; 7(5):565-75. PubMed ID: 15543532
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO.
Krause P; Singer E; Darley PI; Klebensberger J; Groettrup M; Legler DF
J Leukoc Biol; 2007 Nov; 82(5):1106-14. PubMed ID: 17698915
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells.
Jürgens B; Hainz U; Fuchs D; Felzmann T; Heitger A
Blood; 2009 Oct; 114(15):3235-43. PubMed ID: 19625705
[TBL] [Abstract][Full Text] [Related]
14. T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.
Kahler DJ; Mellor AL
Handb Exp Pharmacol; 2009; (188):165-96. PubMed ID: 19031026
[TBL] [Abstract][Full Text] [Related]
15. Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?
Löb S; Ebner S; Wagner S; Weinreich J; Schäfer R; Königsrainer A
Transplantation; 2007 Feb; 83(4):468-73. PubMed ID: 17318080
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine 2,3-dioxygenase expression and functional activity in dendritic cells exposed to cholera toxin.
Slavica L; Nurkkala-Karlsson M; Karlson T; Ingelsten M; Nyström J; Eriksson K
Scand J Immunol; 2012 Aug; 76(2):113-22. PubMed ID: 22519828
[TBL] [Abstract][Full Text] [Related]
17. Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients.
Schulz S; Landi A; Garg R; Wilson JA; van Drunen Littel-van den Hurk S
Clin Exp Immunol; 2015 Jun; 180(3):484-98. PubMed ID: 25605587
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?
Terness P; Chuang JJ; Bauer T; Jiga L; Opelz G
Blood; 2005 Mar; 105(6):2480-6. PubMed ID: 15572592
[TBL] [Abstract][Full Text] [Related]
19. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.
Munn DH; Sharma MD; Mellor AL
J Immunol; 2004 Apr; 172(7):4100-10. PubMed ID: 15034022
[TBL] [Abstract][Full Text] [Related]
20. The mannose receptor negatively modulates the Toll-like receptor 4-aryl hydrocarbon receptor-indoleamine 2,3-dioxygenase axis in dendritic cells affecting T helper cell polarization.
Salazar F; Hall L; Negm OH; Awuah D; Tighe PJ; Shakib F; Ghaemmaghami AM
J Allergy Clin Immunol; 2016 Jun; 137(6):1841-1851.e2. PubMed ID: 26703454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]